NCT06090669 2026-02-17Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 DeficiencyNational Institutes of Health Clinical Center (CC)Phase 1 Recruiting75 enrolled
NCT06655246 2026-02-05A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)Kura Oncology, Inc.Phase 1 Recruiting157 enrolled